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Oral paediatric forms development by pharmaceutical industry is still insufficient.
The present study was performed to propose an adapted and pleasant formulation
of liquid oral formulation of MTX. The solution is composed of injectable
methotrexate, water, Ora Sweet(®) and sodium bicarbonate. After 120 days
storage, pH remained stable at about 8 in all formulations, insuring no risk of MTX
precipitation. MTX content in solution formulation, determined by high
performance liquid chromatography measurements, remained in the specifications
of >90% of the initial concentration when stored at 4 and 25°C. Forced
degradation of MTX by heat and acidic conditions allowed formation and detection
of degradation products by the analytical method. Microbial study of the
preparation shows that the solution remains in the specifications during all the
storage, or after one sample each week during one month, eventually indicating the
microbial properties are not affected by patient use. To conclude, we here propose
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